Avadel Pharmaceuticals PLC at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Good morning. It's my pleasure to introduce our next presenting company, Avadel. Presenting for the company is Greg Divis, CEO. And Greg, we look forward to this chat -- fireside chat that we are going to have.
Questions & Answers
And I want to kick it off with -- I guess for people that aren't familiar with Avadel, can you give us a little bit of a brief background on the Company and your overall vision for the Company as well?
Yes, Matt. First of all, thanks for the opportunity to be here and the chance to participate in your conference. We really greatly appreciate it. Avadel is a biopharmaceutical company that is primarily focused today on the development of our investigational, once-nightly-at-bedtime FT218, which is our once-nightly formulation of sodium oxybate for patients suffering from narcolepsy and specifically patients suffering
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
